Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Five additions to the interaction checker

Friday 09 November 2018

Bortezomib, pertuzumab, thalidomide, trastuzumab and trastuzumab-emtansine are now listed in the interaction checker as cancer drugs and interactions can be found with all the comedications. 

  • Bortezomib (Velcade®) is a proteasome inhibitor and is indicated for the treatment of multiple myeloma and mantle cell lymphoma.
  • Pertuzumab (Perjeta®) is a monoclonal antibody and is indicated for the treatment of breast neoplasms.
  • Thalidomide (Thalidomide Celgene®, Thalomid®) is an immunomodulatory agent and is indicated for the treatment of multiple myeloma.
  • Trastuzumab (Herceptin®) is a monoclonal antibody and is indicated for the treatment of breast neoplasms and stomach neoplasms.
  • Trastuzumab-emtansine (Kadcyla®) is a monoclonal antibody and is indicated for the treatment of breast neoplasms.


ENDORSED BY
Bopa